John Libbey Eurotext

European Journal of Dermatology


A case of systemic lupus erythematosus/systemic sclerosis overlap syndrome successfully treated with belimumab Volume 30, numéro 5, September-October 2020


  • Figure 1
Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan

The pathogenesis of systemic lupus erythematosus (SLE) involves various immune pathways including B cells, innate immunity and T cells [1]. Successful treatments for SLE overlap syndromes are rarely reported [2, 3], but documenting such cases is crucial for the management of the disease. Here we report a case of SLE/systemic sclerosis (Ssc) overlap syndrome in which a long-term successful response to belimumab was demonstrated.The patient was a 31-year-old Japanese female with SLE/Ssc overlap syndrome. [...]